TACE/ADAM‐17 maturation and activation of sheddase activity require proprotein convertase activity
暂无分享,去创建一个
I. Fournier | C. Dubois | R. Day | M. Fugère | N. Srour | S. McMahon | A. Lebel
[1] E. Kojro,et al. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. , 2003, European journal of biochemistry.
[2] I. Juhan-vague,et al. Intracellular maturation and transport of tumor necrosis factor alpha converting enzyme. , 2003, Experimental cell research.
[3] R. Leduc,et al. Processing of proendothelin‐1 by members of the subtilisin‐like pro‐protein convertase family , 2002, FEBS letters.
[4] T. Kang,et al. Intracellular Activation of Human Adamalysin 19/Disintegrin and Metalloproteinase 19 by Furin Occurs via One of the Two Consecutive Recognition Sites* , 2002, The Journal of Biological Chemistry.
[5] J. Kneer,et al. (E)-2(R)-[1(S)-(Hydroxycarbamoyl)-4-phenyl-3-butenyl]-2'-isobutyl-2'-(methanesulfonyl)-4-methylvalerohydrazide (Ro 32-7315), a selective and orally active inhibitor of tumor necrosis factor-alpha convertase. , 2002, The Journal of pharmacology and experimental therapeutics.
[6] T. Kirkegaard,et al. Tumour necrosis factor α converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease , 2002 .
[7] M. Olivotto,et al. Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages , 2002, Oncogene.
[8] C. Walker,et al. Pharmacological profile of PKF242‐484 and PKF241‐466, novel dual inhibitors of TNF‐α converting enzyme and matrix metalloproteinases, in models of airway inflammation , 2002, British journal of pharmacology.
[9] J. Sandy,et al. Activation of the Proteolytic Activity of ADAMTS4 (Aggrecanase-1) by C-terminal Truncation* , 2002, The Journal of Biological Chemistry.
[10] R. Leduc,et al. Inhibitory Potency and Specificity of Subtilase-like Pro-protein Convertase (SPC) Prodomains* , 2002, The Journal of Biological Chemistry.
[11] R. Maki,et al. References Subscriptions Permissions Email Alerts Expression and Regulation of Aggrecanase in Arthritis: The Role of TGF- β , 2013 .
[12] C. Blobel,et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). , 2001, The Journal of biological chemistry.
[13] E. Avner,et al. A novel inhibitor of tumor necrosis factor-alpha converting enzyme ameliorates polycystic kidney disease. , 2001, Kidney international.
[14] D. Skovronsky,et al. Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. , 2001, Journal of neurobiology.
[15] Michael H. Rabinowitz,et al. Inhibition of tumor necrosis factor-alpha (TNF-alpha) production and arthritis in the rat by GW3333, a dual inhibitor of TNF-alpha-converting enzyme and matrix metalloproteinases. , 2001, The Journal of pharmacology and experimental therapeutics.
[16] A. Prat,et al. Inhibition of Proprotein Convertases Is Associated with Loss of Growth and Tumorigenicity of HT-29 Human Colon Carcinoma Cells , 2001, The Journal of Biological Chemistry.
[17] F. Fahrenholz,et al. Regulation of the α‐secretase ADAM10 by its prodomain and proprotein convertases , 2001 .
[18] N. Seidah,et al. Neuroendocrine secretory protein 7B2: structure, expression and functions. , 2001, The Biochemical journal.
[19] N. Seidah,et al. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides , 2001 .
[20] S. Weiss,et al. Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. , 2000, Molecular biology of the cell.
[21] J. Shellito,et al. Inhibition of TNF‐α processing and TACE‐mediated ectodomain shedding by ethanol , 2000, Journal of leukocyte biology.
[22] R. Black,et al. Functional Analysis of the Domain Structure of Tumor Necrosis Factor-α Converting Enzyme* , 2000, The Journal of Biological Chemistry.
[23] C. Blobel,et al. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). , 2000, The Biochemical journal.
[24] A Cumano,et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. , 2000, Molecular cell.
[25] M. Lambert,et al. Specific Sequence Elements Are Required for the Expression of Functional Tumor Necrosis Factor-α-converting Enzyme (TACE)* , 1999, The Journal of Biological Chemistry.
[26] David C. Lee,et al. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. , 1999, Development.
[27] G. Weskamp,et al. Metalloprotease-Disintegrin MDC9: Intracellular Maturation and Catalytic Activity* , 1999, The Journal of Biological Chemistry.
[28] David C. Lee,et al. An essential role for ectodomain shedding in mammalian development. , 1998, Science.
[29] Joseph D. Buxbaum,et al. Evidence That Tumor Necrosis Factor α Converting Enzyme Is Involved in Regulated α-Secretase Cleavage of the Alzheimer Amyloid Protein Precursor* , 1998, The Journal of Biological Chemistry.
[30] L. Lum,et al. Intracellular Maturation of the Mouse Metalloprotease Disintegrin MDC15* , 1998, The Journal of Biological Chemistry.
[31] E. Engvall,et al. Human ADAM 12 (Meltrin α) Is an Active Metalloprotease* , 1998, The Journal of Biological Chemistry.
[32] G. Thomas,et al. alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: application as an antipathogenic agent. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Huber,et al. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[34] N. Seidah,et al. Proprotein Convertases , 2011, Methods in Molecular Biology.
[35] C. Dubois,et al. TGFbeta1 regulates gene expression of its own converting enzyme furin. , 1997, The Journal of clinical investigation.
[36] M. Lambert,et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α , 1997, Nature.
[37] Nicole Nelson,et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells , 1997, Nature.
[38] H. Hamada,et al. Adenovirus-mediated inducible gene expression through tetracycline-controllable transactivator with nuclear localization signal. , 1997, Biochemical and biophysical research communications.
[39] H. Sato,et al. Activation of a recombinant membrane type 1‐matrix metalloproteinase (MT1‐MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)‐2 , 1996, FEBS letters.
[40] G. Butler,et al. The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation , 1996, The Journal of Biological Chemistry.
[41] L. Liotta,et al. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. , 1996, Cancer research.
[42] Hanns Lochmüller,et al. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm. , 1995, American journal of respiratory cell and molecular biology.
[43] Stephen J. Weiss,et al. Furin-dependent intracellular activation of the human stromelysin-3 zymogen , 1995, Nature.
[44] A. Strongin,et al. Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase , 1995, The Journal of Biological Chemistry.
[45] J. A. Spitzer,et al. Prohormone convertases PC2 and PC3 in rat neutrophils and macrophages Parallel changes with proenkephalin-derived peptides induced by LPS in vivo , 1994, Neuropeptides.
[46] S. Takahashi,et al. A mutation of furin causes the lack of precursor-processing activity in human colon carcinoma LoVo cells. , 1993, Biochemical and biophysical research communications.
[47] M. Komada,et al. Proteolytic processing of the hepatocyte growth factor/scatter factor receptor by furin , 1993, FEBS letters.
[48] M Chrétien,et al. cDNA structure of the mouse and rat subtilisin/kexin-like PC5: a candidate proprotein convertase expressed in endocrine and nonendocrine cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Chrétien,et al. Gene expression of prohormone and proprotein convertases in the rat CNS: a comparative in situ hybridization analysis , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[50] T Watanabe,et al. Identification and functional expression of a new member of the mammalian Kex2-like processing endoprotease family: its striking structural similarity to PACE4. , 1993, Journal of biochemistry.
[51] L Devi,et al. Consensus sequence for processing of peptide precursors at monobasic sites , 1991, FEBS letters.
[52] N. Seidah,et al. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. , 2001, The American journal of pathology.
[53] L. Bourget,et al. Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products. , 1997, BioTechniques.